3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
5
Melanoma
3
Cholangiocarcinoma
3
Breast Neoplasms
3
Sarcoma
2
Osteosarcoma
2
Liver Neoplasms
2
Kidney Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Unresectable Solid Tumors
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Pancreatic Adenocarcinoma Locally Advanced
1
Neuroblastoma
1
Lung Neoplasms
1
Liver Metastasis
1
High-Burden Metastatic Solid Tumors
1
Hepatoblastoma
1
Gastric Cancer Metastatic to Liver
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Desmoid Tumors
1
Colonic Neoplasms
1
Interventions
tislelizumab
1
pembrolizumab
1
patritumab deruxtecan
1
leronlimab
1
lenvatinib
1
atezolizumab
1
Tiragolumab
1
Radiotherapy
1
Cryosurgery
1
3-amino-1-methyl-3-(4-(3-phenyl-5H- imidazo(1,2-c)pyrido(3,4-e)(1,3)oxazin-2-yl)phenyl)cyclobutanol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Solid Tumor, Adult
×
Cryosurgery
×
Clear all
NCT06032845
2025-02-27
CASTLE-11
Fudan University
Phase 2
Recruiting
25 enrolled